Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.
Sign Up to like & getrecommendations! Published in 2020 at "Nature medicine"
DOI: 10.1038/s41591-020-1085-z
Abstract: Preoperative immunotherapy with anti-PD1 plus anti-CTLA4 antibodies has shown remarkable pathological responses in melanoma1 and colorectal cancer2. In NABUCCO (ClinicalTrials.gov: NCT03387761), a single-arm feasibility trial, 24 patients with stage III urothelial cancer (UC) received two… read more here.
Keywords: plus nivolumab; urothelial cancer; trial; locoregionally advanced ... See more keywords